SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

Go Beyond the Angiogram

Comprehensive Physiology Indices

Go Beyond the Angiogram
Physiology Indices

Why Using Physiological Indices Is Essential

Physiological measurements, including hyperemic (FFR) and non-hyperemic pressure ratios (NHPR), Index of Microcirculatory Resistance (IMR), and Coronary Flow Reserve (CFR) are used to assess for epicardial disease and microvascular dysfunction. Physiologic data from PressureWire™ X Guidewire leads to informed decision-making that is proven to improve patient outcomes and prevent unnecessary, repeat hospitalizations.1

Physiological Indices Defined

Objective Diagnosis of Epicardial Disease and Microvascular Dysfunction

View how PressureWire™ X Guidewire measures Fractional Flow Reserve (FFR), Resting Full-cycle Ratio (RFR), Index of Microcirculatory Resistance (IMR) and Coronary Flow Reserve (CFR).

PressureWire X Guidewire
Assessing the Microcirculation

Test your knowledge of physiological indices with our quiz

Start Quiz
Physiology Indices

Physiology-Guided Decision Making Leads to Better Outcomes

Determining the Need for Revascularization
Determining the Need for Revascularization
Assessment for a Coronary Microvascular Dysfunction Diagnosis
Assessment for a Coronary Microvascular Dysfunction Diagnosis

Society Guidelines for Physiologic Indices

 Diagnosing Epicardial StenosisDiagnosing Coronary Microvascular Dysfunction
 FFRRFRIMRCFR
GuidelinesACC/SCAI (view here)
ESC Guideline 2019 (view here)
AHA/ACC Guidelines (view here)
Cutoff Value≤ 0.82≤ 0.893≥ 251,*< 2.51,*
FormulaPd/Pa at hyperemiaLowest Pd/Pa ratio of whole-cyclePd x Hyperemic FlowHyperemic Flow/Baseline Flow
HyperemiaYesNoYesYes

*IMR and CFR cutoffs in population of ischemia with no obstructive coronary artery disease (INOCA) patients, CorMicA trial.1

RFR is recognized by the Appropriate Use Criteria with an approved coding recommendation by ACC/SCAI.

Assessing whether Epicardial Stenosis needs intervention because there's more to CAD than an angiogram shows

Assessing Coronary Microvascular Dysfunction (CMD) because CMD may contribute to recurrent angina

References

  1. Ford TJ, et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). J Am Coll Card Intu. 2020;13:33-45.
  2. Jeremias A, et al. A test in context: fractional flow reserve: accuracy, prognostic implications, and limitations. J Am Coll Cardiol. 2017;69(22):2748-2758.
  3. Kobayashi Y, et al. Agreement of the resting distal to aortic coronary pressure with the instantaneous wave-free ratio. J Am Coll Cardiol. 2017;70(17):2105-2113.

MAT-2003863 v3.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2001111 v8.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0